Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada.
Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada.
PLoS One. 2022 Oct 14;17(10):e0276010. doi: 10.1371/journal.pone.0276010. eCollection 2022.
Salmonella is an intracellular pathogen causing significant morbidity and mortality. Its ability to grow inside macrophages is important to virulence, and is dependent on the activation state of the macrophages. Classically activated M1 macrophages are non-permissive for Salmonella growth, while alternatively activated M2 macrophages are permissive for Salmonella growth. Here we showed that endotoxin-primed macrophages (MEP), such as those associated with sepsis, showed similar levels of Salmonella resistance to M1 macrophages after 2 hr of intracellular infection, but at the 4 hr and 24 hr time points were susceptible like M2 macrophages. To understand this mechanistically, transcriptomic sequencing, RNA-Seq, was performed. This showed that M1 and MEP macrophages that had not been exposed to Salmonella, demonstrated a process termed here as primed activation, in expressing relatively higher levels of particular anti-infective genes and pathways, including the JAK-STAT (Janus kinase-signal transducer and activator of transcription) pathway. In contrast, in M2 macrophages these genes and pathways were largely expressed only in response to infection. Conversely, in response to infection, M1 macrophages, but not MEP macrophages, modulated additional genes known to be associated with susceptibility to Salmonella infection, possibly contributing to the differences in resistance at later time points. Application of the JAK inhibitor Ruxolitinib before infection reduced resistance in M1 macrophages, supporting the importance of early JAK-STAT signalling in M1 resistance to Salmonella.
沙门氏菌是一种细胞内病原体,可导致严重的发病率和死亡率。它在巨噬细胞内生长的能力对其毒力很重要,这取决于巨噬细胞的激活状态。经典激活的 M1 巨噬细胞对沙门氏菌的生长不允许,而替代性激活的 M2 巨噬细胞则允许沙门氏菌生长。在这里,我们表明,内毒素预处理的巨噬细胞(MEP),如与败血症相关的巨噬细胞,在细胞内感染 2 小时后对沙门氏菌的抵抗力与 M1 巨噬细胞相似,但在 4 小时和 24 小时时间点与 M2 巨噬细胞一样易感。为了从机制上理解这一点,我们进行了转录组测序,RNA-Seq。这表明,未暴露于沙门氏菌的 M1 和 MEP 巨噬细胞表现出一种称为预先激活的过程,即在表达相对较高水平的特定抗感染基因和途径方面,包括 JAK-STAT(Janus kinase-signal transducer and activator of transcription)途径。相比之下,在 M2 巨噬细胞中,这些基因和途径仅在感染后才大量表达。相反,在感染后,M1 巨噬细胞,但不是 MEP 巨噬细胞,调节了另外一些已知与沙门氏菌感染易感性相关的基因,这可能导致在后期时间点对感染的抵抗力不同。在感染前应用 JAK 抑制剂鲁索替尼(Ruxolitinib)降低了 M1 巨噬细胞的抵抗力,支持 JAK-STAT 信号通路在 M1 抵抗沙门氏菌感染早期的重要性。